Biotinylated Human Siglec-3 / CD33 by AMSBIO

Manufacturer AMSBIO  |   Model: AMS.CD3-H82E7  |  Available Worldwide
MABSol®Biotinylated Human Siglec-3 / CD33, His Tag (CD3-H82E7) is expressed from human 293 cells (HEK293). It contains AA Asp 18 - His 259 (Accession # AAH28152.1).


Biotinylated Human Siglec-3 / CD33  by AMSBIO product image
Biotinylated Human Siglec-3 / CD33
Request Pricing

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

MABSol®Biotinylated Human Siglec-3 / CD33, His Tag (CD3-H82E7) is expressed from human 293 cells (HEK293). It contains AA Asp 18 - His 259 (Accession # AAH28152.1). Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin. Myeloid cell surface antigen CD33 also known as SIGLEC3, Siglecs (sialic acid binding Ig­like lectins) and GP67, is a singlepass type I membrane protein which belongs to the immunoglobulin superfamily and SIGLEC (sialic acid binding Ig-like lectin) family. Human CD33 / Siglec-3 cDNA encodes a 364 amino acid (aa) polypeptide with a hydrophobic signal peptide, an N-­terminal Ig-­like V­-type domain, one Ig­-like C2-­type domains, a transmembrane region and a cytoplasmic tail. CD33 / Siglec-3 usually considered myeloid-specific, but it can also be found on some lymphoid cells. In the immune response, CD33 /Siglec-3 may act as an inhibitory receptor upon ligand induced tyrosine phosphorylation by recruiting cytoplasmic phosphatase(s) via their SH2 domain(s) that block signal transduction through dephosphorylation of signaling molecules. CD33/ Siglec-3 induces apoptosis in acute myeloid leukemia.